Clinical trials
Phase 1/2 Endometrial Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 12 |
| 2022 | 7 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 37 |
| Completed | 17 |
| Terminated | 15 |
| Active, not recruiting | 6 |
| Not yet recruiting | 4 |
| Suspended | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genmab | 4 |
| AstraZeneca | 3 |
| Incyte Biosciences International Sàrl | 3 |
| Incyte Corporation | 3 |
| Advenchen Pharmaceuticals, LLC. | 2 |
| Eisai Inc. | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 83 |
| Ovarian Neoplasms | 51 |
| Breast Neoplasms | 28 |
| Colorectal Neoplasms | 28 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Uterine Cervical Neoplasms | 27 |
| Stomach Neoplasms | 19 |
| Triple Negative Breast Neoplasms | 19 |
| Neoplasms | 17 |
| Melanoma | 16 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.